Trypsin-Chymotripsin and Diclofenac Potassium Tablets

About Trypsin-Chymotripsin and Diclofenac Potassium Tablets

Accessible in 10x 10 strips, Trypsin-Chymotripsin and Diclofenac Potassium Tablets are effective in reducing inflammatory feeling and pain. Trylas-D tablets contain trypsin chymotrypsin in 6:1 proportion and diclofenac pota in 50 mg. As fibrinolytic agents, these allopathic tablets are effective in dissolving clotted blood, in removing dead tissues and in avoiding multiplication of pathogens in human body. Trypsin-Chymotripsin and Diclofenac Potassium Tablets improve enhances strength of capillaries wall of blood and blocks production of bradykinin in inflammation infected body parts. Standard of these tablets has been verified on the basis of their packaging standard, storage life, mode of action and possible side effects. 

Composition :

• Trypsin Chymotrypsin (6:1) + Diclofenac Pota. 50 mg.

Powerful Dual-Action Formula

This product combines Trypsin-Chymotrypsin, a synergistic enzyme pair, with the anti-inflammatory agent Diclofenac Potassium. Together, they help to break down inflammatory proteins and block pain pathways, resulting in quicker and more comprehensive relief. Ideal for managing post-surgical swelling and various inflammatory conditions.


Safe and Convenient Packaging

Supplied in sturdy commercial cartons with detailed leaflet inserts, each carton holds blister packs totaling 100 tablets. The tablets are designed for easy oral administration, with clear dosage guidelines provided for adult use as prescribed by a physician. Storage at temperatures below 25C ensures long-term potency and stability.


Quality & Regulatory Assurance

Manufactured under stringent quality standards, these tablets are suitable for both export and domestic supply within India. They are intended strictly for adult use and are available only via prescription, ensuring that their administration meets clinical safety and patient health requirements.